Welcome to the September edition of the Baker McKenzie Ukraine Healthcare Industry Group Newsletter. This is your regular digest of legal developments affecting the life science and healthcare industries in Ukraine.
This edition covers changes in the regulation of public procurement of pharmaceuticals, including changes that suspend procurement based on the National Essential Medicines List, and an update of the list of pharmaceuticals to be procured by specialized procurement agencies. This edition also covers an update of the register of reference (reimbursement) prices for insulin preparations, implementing bylaws regarding inspections of compliance with licensing conditions and expected changes to migration laws by the end of 2017. More details on these developments affecting the Ukrainian life science and healthcare industries are provided below.
In this issue:
- Public procurement of pharmaceuticals
- Reference pricing and reimbursement
- Licensing conditions
- Migration laws
- The MapApp: Laws and Regulations